Company / EPS (Basic)
Praxis Precision Medicines, Inc. EPS (Basic) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$18.69
FY2025
5-year range
-$69.65 / -$3.94
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
#207 of 208
Health Care
What the data says
Among 208 Health Care companies, Praxis Precision Medicines, Inc. is in the bottom 0% for eps (basic). Improved from $-69.65 to $-18.69 over the past 2 years.
Based on SEC 10-K filings.
-18.69 in FY2025.
Improved from $-69.65 to $-18.69 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in Health CareTop 100% of 208This company -$18.69 Sector average -$0.87
▼
-2046.7% below sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 0.0% year-over-year.
- Ranks #207 out of 208 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2021.
- Lowest eps (basic) in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 4.48 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$18.69 | +0.0% |
| FY2024 | -$18.69 | +73.2% |
| FY2023 | -$69.65 | +0.0% |
| FY2022 | -$69.65 | -1667.8% |
| FY2021 | -$3.94 | +49.9% |
| FY2020 | -$7.86 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026